Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse

Experimental Cell Research

Volumn 258, Issue 1, 2000, Pages 162-170

  Bakker, Cathy E ^a   De Diego Otero, Yolanda ^a   Bontekoe, Carola ^a   Raghoe, Prawien ^a   Luteijn, Tanya ^a   Hoogeveen, André T ^a   Oostra, Ben A ^a   Willemsen, Rob ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Fmrp; Fragile X syndrome; Fxr1p; Fxr2p; Localization; Mouse tissues

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; PROTEIN FXR1; PROTEIN FXR2; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FRAGILE X SYNDROME; INTRACELLULAR TRANSPORT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; TISSUE DISTRIBUTION; TISSUE LEVEL;

ANIMALIA; RODENTIA;

EID: 0342757873     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4932     Document Type: Article

References (40)

1. Oberlé I., Boue J., Croquette M. F., Voelckel M. A., Mattei M. G., Mandel J. L. Three families with high expression of a fragile site at Xq27.3, lack of anomalies at the FMR-1 CpG island, and no clear phenotypic association. Am. J. Med. Genet. 43:1992;224-231.
2. Yu S., Pritchard M., Kremer E., Lynch M., Nancarrow J., Baker E., Holman K., Mulley J. C., Warren S. T., Schlessinger D., Sutherland G. R., Richards R. I. Fragile X genotype characterized by an unstable region of DNA. Science. 252:1991;1179-1181.
3. Fu Y. H., Kuhl D. P., Pizzuti A., Pieretti M., Sutcliffe J. S., Richards S., Verkerk A. J., Holden J. J., Fenwick R. Jr., Warren S. T., Oostra B. A., Nelson D. L., Caskey C. T. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell. 67:1991;1047-1058.
4. Kremer E. J., Pritchard M., Lynch M., Yu S., Holman K., Baker E., Warren S. T., Schlessinger D., Sutherland G. R., Richards R. I. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science. 252:1991;1711-1714.
5. Pieretti M., Zhang F. P., Fu Y. H., Warren S. T., Oostra B. A., Caskey C. T., Nelson D. L. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 66:1991;817-822.
6. Verheij C., Bakker C. E., de Graaff E., Keulemans J., Willemsen R., Verkerk A. J., Galjaard H., Reuser A. J., Hoogeveen A. T., Oostra B. A. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature. 363:1993;722-724.
7. Devys D., Lutz Y., Rouyer N., Bellocq J. P., Mandel J. L. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nature Genet. 4:1993;335-340.
8. Hagerman R. J. Physical and behavioral phenotype. Hagerman R. J., Silverman A. C. Fragile X Syndrome: Diagnosis, Treatment and Research. 1996;3-87 The John Hopkins University Press, Baltimore.
9. De Vries B. B. A., Halley D. J. J., Oostra B. A., Niermeijer M. F. The fragile X syndrome. J. Med. Genet. 35:1998;579-589.
10. De Vries B. B., van den Ouweland A. M., Mohkamsing S., Duivenvoorden H. J., Mol E., Gelsema K., van Rijn M., Halley D. J., Sandkuijl L. A., Oostra B. A., Tibben A., Niermeijer M. F. Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am. J. Hum. Genet. 61:1997;660-667.
11. Verkerk A. J., Pieretti M., Sutcliffe J. S., Fu Y. H., Kuhl D. P., Pizzuti A., Reiner O., Richards S., Victoria M. F., Zhang F. P., Eussen B. E., Van Ommen G. J. B., Blonden L. A. J., Riggins G. J., Chastain J. L., Kunst C. B., Galjaard H., Caskey C. T., Nelson D. L., Oostra B. A., Warren S. T. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 65:1991;905-914.
12. Verkerk A. J., De Graaff E., De Boulle K., Eichler E. E., Konecki D. S., Reyniers E., Manca A., Poustka A., Willems P. J., Nelson D. L., Oostra B. A. Alternative splicing in the fragile X gene FMR1. Hum. Mol. Genet. 2:1993;399-404.
13. Bächner D., Steinbach P., Wöhrle D., Just W., Vogel W., Hameister H., Manca A., Poustka A. Enhanced Fmr-1 expression in testis. Nature Genet. 4:1993;115-116.
14. Bächner D., Manca A., Steinbach P., Wöhrle D., Just W., Vogel W., Hameister H., Poustka A. Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and the female gonad. Hum. Mol. Genet. 2:1993;2043-2050.
15. Hinds H. L., Ashley C. T., Sutcliffe J. S., Nelson D. L., Warren S. T., Housman D. E., Schalling M. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nature Genet. 3:1993;36-43.
16. Abitbol M., Menini C., Delezoide A. L., Rhyner T., Vekemans M., Mallet J. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nature Genet. 4:1993;147-153.
17. Agulhon C., Blanchet P., Kobetz A., Marchant D., Faucon N., Sarda P., Moraine C., Sittler A., Biancalana V., Malafosse A., Abitbol M. Expression of FMR1, FXR1, and FXR2 genes in human prenatal tissues. J. Neuropathol. Exp. Neurol. 58:1999;867-880.
18. Malter H. E., Iber J. C., Willemsen R., De Graaff E., Tarleton J. C., Leisti J., Warren S. T., Oostra B. A. Characterization of the full fragile X syndrome mutation in fetal gametes. Nature Genet. 15:1997;165-169.
19. Tamanini F., Willemsen R., van Unen L., Bontekoe C., Galjaard H., Oostra B. A., Hoogeveen A. T. Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum. Mol. Genet. 6:1997;1315-1322.
20. Khandjian E. W., Bardoni B., Corbin F., Sittler A., Giroux S., Heitz D., Tremblay S., Pinset C., Montarras D., Rousseau F., Mandel J. Novel isoforms of the fragile X related protein FXR1P are expressed during myogenesis. Hum. Mol. Genet. 7:1998;2121-2128.
21. Verheij C., De Graaff E., Bakker C. E., Willemsen R., Willems P. J., Meijer N., Galjaard H., Reuser A. J. J., Oostra B. A., Hoogeveen A. T. Characterization of FMR1 proteins isolated from different tissues. Hum. Mol. Genet. 4:1995;895-901.
22. Feng Y., Gutekunst C. A., Eberhart D. E., Yi H., Warren S. T., Hersch S. M. Fragile X mental retardation protein: Nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J. Neurosci. 17:1997;1539-1547.
23. Willemsen R., Bontekoe C., Tamanini F., Galjaard H., Hoogeveen A. T., Oostra B. A. Association of FMRP with ribosomal precursor particles in the nucleolus. Biochem. Biophys. Res. Commun. 225:1996;27-33.
24. Siomi M. C., Siomi H., Sauer W. H., Srinivasan S., Nussbaum R. L., Dreyfuss G. FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J. 14:1995;2401-2408.
25. Zhang Y., Oconnor J. P., Siomi M. C., Srinivasan S., Dutra A., Nussbaum R. L., Dreyfuss G. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J. 14:1995;5358-5366.
26. Eberhart D. E., Malter H. E., Feng Y., Warren S. T. The fragile X mental retardation protein is a ribosonucleoprotein containing both nuclear localization and nuclear export signals. Hum. Mol. Genet. 5:1996;1083-1091.
27. Corbin F., Bouillon M., Fortin A., Morin S., Rousseau F., Khandjian E. W. The fragile X mental retardation protein is associated with poly(A)(+) mRNA in actively translating polyribosomes. Hum. Mol. Genet. 6:1997;1465-1472.
28. Tamanini F., Van Unen L., Bakker C., Sacchi N., Galjaard H., Oostra B. A., Hoogeveen A. T. Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P. Biochem. J. 343:1999;517-523.
29. Coy J. F., Sedlacek Z., Bachner D., Hameister H., Joos S., Lichter P., Delius H., Poustka A. Highly conserved 3′UTR and expression pattern of FXR1 points to a divergent gene regulation of FXR1 and FMR1. Hum. Mol. Genet. 4:1995;2209-2218.
30. Feng Y., Absher D., Eberhart D. E., Brown V., Malter H. E., Warren S. T. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell. 1:1997;109-118.
31. Ceman S., Brown V., Warren S. T. Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Mol. Cell. Biol. 19:1999;7925-7932.
32. Ginisty H., Sicard H., Roger B., Bouvet P. Structure and functions of nucleolin. J. Cell Sci. 112:1999;761-772.
33. Tamanini F., Bontekoe C., Bakker C. E., van Unen L., Anar B., Willemsen R., Yoshida M., Galjaard H., Oostra B. A., Hoogeveen A. T. Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations. Hum. Mol. Genet. 8:1999;863-869.
34. Bardoni B., Schenck A., Mandel J. L. A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein. Hum. Mol. Genet. 8:1999;2557-2566.
35. Huang S., Deerinck T. J., Ellisman M. H., Spector D. L. The perinucleolar compartment and transcription. J. Cell Biol. 143:1998;35-47.
36. Lamond A. I., Earnshaw W. C. Structure and function in the nucleus. Science. 280:1998;547-553.
37. Hendriksen P. J. M., Hoogerbrugge J. W., Themmen A. P. N., Koken M. H. M., Hoeijmakers J. H. J., Oostra B. A., Van Der Lende T., Grootegoed J. A. Postmeiotic transcription of X and Y chromsomal genes during spermatogenesis in the mouse. Dev. Biol. 170:1995;730-733.
38. Slegtenhorst-Eegdeman K. E., van de Kant H. J. G., Post M., Ruiz A., Uilenbroek J. T. J., Bakker C. E., Oostra B. A., Grootegoed J. A., de Rooij D. G., Themmen A. P. N. Macro-orchidism in FMR1 knockout mice is caused by increased Sertoli cell proliferation during testis development. Endocrinology. 139:1998;156-162.
39. Allingham-Hawkins D. J., Babul-Hirji R., Chitayat D., Holden J. J., Yang K. T., Lee C., Hudson R., Gorwill H., Nolin S. L., Glicksman A., Jenkins E. C., Brown W. T., Howard-Peebles P. N., Becchi C., Cummings E., Fallon L., Seitz S., Black S. H., Vianna-Morgante A. M., Costa S. S., Otto P. A., Mingroni-Netto R. C., Murray A., Webb J., Vieri F. Fragile X premutation is a significant risk factor for premature ovarian failure: The International Collaborative POF in Fragile X study - preliminary data. Am. J. Med. Genet. 83:1999;322-325.
40. Hundscheid R. D. L., Sistermans E. A., Thomas C. M. G., Braat D. D. M., Straatman H., Kiemeney L. A. L. M., Oostra B. A., Smits A. P. T. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations. Am. J. Hum. Genet. 66:2000;413-418.